Canopy Growth(US:CGC) ZACKS·2026-01-23 00:01Group 1 - Canopy Growth Corporation (CGC) closed at $1.17, with a daily increase of +2.8%, outperforming the S&P 500's gain of 0.55% [1] - The stock has decreased by 12.98% over the past month, underperforming the Medical sector's gain of 0.19% and the S&P 500's gain of 0.71% [1] Group 2 - The upcoming earnings disclosure for Canopy Growth Corporation is anticipated, with projected earnings per share (EPS) of -$0.03, reflecting a 96.05% increase from the same quarter last year [2] - Revenue is forecasted to be $50.59 million, indicating a 5.34% decline compared to the same quarter of the previous year [2] Group 3 - For the entire fiscal year, Zacks Consensus Estimates predict an EPS of -$0.21 and revenue of $199.68 million, showing changes of +92.95% and +3.3% respectively from the previous year [3] Group 4 - Recent changes to analyst estimates for Canopy Growth Corporation indicate short-term business trends, with positive revisions suggesting optimism about the business outlook [4] - Estimate changes are correlated with near-term stock prices, and the Zacks Rank system has been developed to capitalize on this correlation [5] Group 5 - The Zacks Rank system ranges from 1 (Strong Buy) to 5 (Strong Sell), with 1 stocks delivering an average annual return of +25% since 1988 [6] - Canopy Growth Corporation currently holds a Zacks Rank of 3 (Hold), with no changes in the Zacks Consensus EPS estimate over the past month [6] Group 6 - The Medical - Products industry, part of the Medical sector, holds a Zacks Industry Rank of 156, placing it in the bottom 37% of over 250 industries [7] - The Zacks Industry Rank assesses the strength of industry groups, with top-rated industries outperforming the bottom half by a factor of 2 to 1 [7]